Long-Term Outcomes After Stenting of Bifurcation Lesions With the "Crush" Technique. Predictors of an Adverse Outcome

Journal of the American College of Cardiology

Volumn 47, Issue 10, 2006, Pages 1949-1958

  Hoye, Angela ^a   Iakovou, Ioannis ^b   Ge, Lei ^b   van Mieghem, Carlos A G ^a   Ong, Andrew T L ^a   Cosgrave, John ^b   Sangiorgi, Giuseppe M ^b   Airoldi, Flavio ^b   Montorfano, Matteo ^b   Michev, Iassen ^b   Chieffo, Alaide ^b   Carlino, Mauro ^b   Corvaja, Nicola ^b   Aoki, Jiro ^a   Rodriguez Granillo, Gaston A ^a   Valgimigli, Marco ^a   Sianos, Georgios ^a   van der Giessen, Willem J ^a   de Feyter, Pim J ^a   van Domburg, Ron T ^a   Serruys, Patrick W ^a   Colombo, Antonio ^b   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON CATHETER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; SURVIVAL; THROMBOSIS; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646255095     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.11.083     Document Type: Article

References (30)

1. Al Suwaidi J., Yeh W., Cohen H.A., Detre K.M., Williams D.O., and Holmes Jr. D.R. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era. (NHLBI dynamic registry). Am J Cardiol 87 (2001) 1139-1144
2. Grube E., Silber S., Hauptmann K.E., et al. TAXUS I. six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
3. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
5. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
6. Tanabe K., Hoye A., Lemos P.A., et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 94 (2004) 115-118
7. Colombo A., Moses J.W., Morice M.C., et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109 (2004) 1244-1249
8. Pan M., de Lezo J.S., Medina A., et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions. a randomized comparison of a simple versus complex strategy. Am Heart J 148 (2004) 857-864
9. Colombo A., Stankovic G., Orlic D., et al. Modified T-stenting technique with crushing for bifurcation lesions. immediate results and 30-day outcome. Catheter Cardiovasc Interv 60 (2003) 145-151
10. Ge L., Airoldi F., Iakovou I., et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique. importance of final kissing balloon post-dilation. J Am Coll Cardiol 46 (2005) 613-620
11. Cutlip D.E., Baim D.S., Ho K.K., et al. Stent thrombosis in the modern era. a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
12. Jeremias A., Sylvia B., Bridges J., et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
13. Chieffo A., Bonizzoni E., Orlic D., et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents. Circulation 109 (2004) 2732-2736
14. Lansky A.J., Dangas G., Mehran R., et al. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 39 (2002) 274-280
15. Pan M., Suarez de Lezo J., Medina A., et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 83 (1999) 1320-1325
16. Yamashita T., Nishida T., Adamian M.G., et al. Bifurcation lesions. two stents versus one stent-immediate and follow-up results. J Am Coll Cardiol 35 (2000) 1145-1151
17. Al Suwaidi J., Berger P.B., Rihal C.S., et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 35 (2000) 929-936
18. Lefevre T., Louvard Y., Morice M.C., et al. Stenting of bifurcation lesions. classification, treatments, and results. Catheter Cardiovasc Interv 49 (2000) 274-283
19. Anzuini A., Briguori C., Rosanio S., et al. Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings. Am J Cardiol 88 (2001) 1246-1250
20. Arampatzis C.A., Lemos P.A., Hoye A., et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease. six-month angiographic follow-up and 1-year clinical outcome. Catheter Cardiovasc Interv 62 (2004) 292-296 discussion, 297
21. Park S.J., Kim Y.H., Lee B.K., et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis. comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
22. Chieffo A., Stankovic G., Bonizzoni E., et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
23. Valgimigli M., van Mieghem C.A., Ong A.T., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease. insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries. (RESEARCH and T-SEARCH). Circulation 111 (2005) 1383-1389
24. Ormiston J.A., Currie E., Webster M.W., et al. Drug-eluting stents for coronary bifurcations. insights into the crush technique. Catheter Cardiovasc Interv 63 (2004) 332-336
25. Castagna M.T., Mintz G.S., Leiboff B.O., et al. The contribution of "mechanical" problems to in-stent restenosis. an intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions. Am Heart J 142 (2001) 970-974
26. Fujii K., Mintz G.S., Kobayashi Y., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109 (2004) 1085-1088
27. Takebayashi H., Kobayashi Y., Mintz G.S., et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 95 (2005) 498-502
28. Takebayashi H., Kobayashi Y., Dangas G., et al. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion. Catheter Cardiovasc Interv 60 (2003) 496-499
29. Colombo A. Bifurcational lesions and the "crush" technique. understanding why it works and why it doesn't-a kiss is not just a kiss. Catheter Cardiovasc Interv 63 (2004) 337-338
30. Morice MC M.C. Presented at:. A prospective, randomized, multi-center comparison study of the Cypher Sirolimus-eluting and Taxus paclitaxel-eluting stent systems (2005), American College of Cardiology Annual Scientific Meeting, Orlando, FL